NEW HAVEN, Conn., Aug. 2, 2011 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, will release second quarter 2011 financial results on Monday, August 8, 2011 after the U.S. financial markets close. Achillion executives will host a conference call and simultaneous webcast on Tuesday, August 9, 2011 at 10:30 a.m. EDT to review the financial results and to provide an update on Achillion's portfolio of HCV compounds and upcoming milestones.
Conference Call Details
To participate in the conference call, investors can dial (877) 354-0215 in the U.S. or (408) 427-3695 for international callers. The conference call ID is 86825307.
A live audio webcast of the call will be accessible at www.achillion.com under the News Center section of the website. Please connect to Achillion's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
A replay of the webcast will be available on www.achillion.com. Alternatively, a replay of the conference call will be available starting at 1:30 p.m. Eastern time on August 9, 2011, through 11:59 p.m. Eastern time on August 16, 2011 by dialing (855) 859-2056 or (404) 537-3406. The replay passcode is 86825307.
About Achillion Pharmaceuticals
Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including hepatitis C and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.